On this page
RNASEH2C
ribonuclease H2 subunit C
The RNASEH2C gene provides instructions for a key component of the RNase H2 complex, an enzyme vital for processing RNA-DNA hybrid molecules and maintaining genomic stability. The RNASEH2C gene encodes the C subunit of the ribonuclease H2 complex, an enzyme essential for cellular processes.
RNASEH2C is located on the long (q) arm of chromosome 11, at band 11q13.1. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 11 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The RNASEH2C gene encodes one subunit of the RNase H2 complex, a group of proteins critical for cellular function. This complex acts as a ribonuclease, an enzyme that specifically degrades RNA molecules. Its primary role involves the breakdown of RNA-DNA hybrid structures, which are transiently formed during DNA replication and repair processes.
Dysfunction of the RNASEH2C gene and the resulting RNase H2 complex can have significant health implications, as it is associated with conditions like Aicardi-Goutières syndrome, a severe neurodevelopmental disorder.
What the gene does
The RNASEH2C gene is responsible for producing the C subunit of the RNase H2 complex. This complex is a ribonuclease enzyme, meaning it facilitates the hydrolysis of RNA. Specifically, the RNase H2 complex targets RNA-DNA hybrids, which are molecular structures composed of one strand of RNA bound to one strand of DNA. These hybrids naturally arise during DNA replication.
Beyond processing RNA-DNA hybrids, the RNase H2 complex is thought to be involved in DNA replication and the repair of errors that can occur during this process. It also contributes to immune system regulation by helping to clear unnecessary DNA fragments that might otherwise trigger an unwanted immune response.
Video: Genetics 101
Chromosome location
The RNASEH2C gene is located on chromosome 11, specifically at position 11q13.1. This genomic location positions the gene within the long arm of chromosome 11, providing its precise address within the human genome.
Protein structure
The RNASEH2C gene codes for a protein consisting of 164 amino acids. The protein structure includes a region identified as Disordered, spanning amino acids 91-112. This disordered region may allow for flexibility and dynamic interactions with other molecules or protein subunits.
Key variants
Genetic variations, often referred to as variants or mutations, can occur within the RNASEH2C gene. These changes can alter the gene's instructions, potentially leading to a dysfunctional or non-functional protein product. The impact of such variants can vary widely, from having no observable effect to contributing to severe health conditions.
Sample of pathogenic variants
2 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.205C>T | p.Arg69Trp | Pathogenic/Likely pathogenic | ★★☆☆ | RNASEH2C-related disorder |
c.215_218delinsTGGC | p.Glu72_Val73delinsValAla | Pathogenic | ★☆☆☆ | Aicardi Goutieres syndrome |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Variants in the RNASEH2C gene are associated with Aicardi-Goutières syndrome. This is a severe disorder characterised by significant brain dysfunction, often presenting as encephalopathy, alongside other symptoms such as skin lesions. These genetic changes likely impair the function of the RNase H2 complex, leading to the clinical manifestations of the syndrome.
No condition pages are linked to this gene yet. This does not mean it has no associated conditions.
UK clinical status
The RNASEH2C gene is included in several NHS Genomic Medicine Service national testing panels, indicating its recognised clinical significance in the UK. It is categorised as 'green' for conditions such as COVID-19 research, DDG2P, and inherited white matter disorders. This gene is also assessed for its role in childhood-onset dystonia, chorea, or related movement disorders (R57), early onset or syndromic epilepsy, and foetal anomalies (R21). Further inclusions cover intellectual disability, intracerebral calcification disorders, adult-onset leukodystrophy (R62), likely inborn errors of metabolism (R98), primary immunodeficiency or monogenic inflammatory bowel disease (R15), and white matter disorders and cerebral calcification in childhood.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the primary function of the RNASEH2C gene?
The RNASEH2C gene provides instructions for making one part of the RNase H2 complex, an enzyme that primarily breaks down RNA-DNA hybrid molecules formed during DNA replication and repair, and contributes to immune system function.
What condition is associated with variants in the RNASEH2C gene?
Variants in the RNASEH2C gene are associated with Aicardi-Goutières syndrome, a severe disorder involving brain dysfunction, skin lesions, and other health issues.
Where is the RNASEH2C gene located?
The RNASEH2C gene is found on chromosome 11, specifically at the 11q13.1 position.
References
- Feng S, Cao Z. Is the role of human RNase H2 restricted to its enzyme activity? Progress in biophysics and molecular biology. 2016. PMID: 26603688
- Livingston JH, Crow YJ. Neurologic Phenotypes Associated with Mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR1, and IFIH1: Aicardi-Goutières Syndrome and Beyond. Neuropediatrics. 2016. PMID: 27643693
- Crow YJ, Chase DS, Lowenstein Schmidt J. Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. American journal of medical genetics. Part A. 2015. PMID: 25604658
- Cuadrado E, Michailidou I, van Bodegraven EJ. Phenotypic variation in Aicardi-Goutières syndrome explained by cell-specific IFN-stimulated gene response and cytokine release. Journal of immunology (Baltimore, Md. : 1950). 2015. PMID: 25769924
- Rice GI, Forte GM, Szynkiewicz M. Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. The Lancet. Neurology. 2013. PMID: 24183309
- Chon H, Vassilev A, DePamphilis ML. Contributions of the two accessory subunits, RNASEH2B and RNASEH2C, to the activity and properties of the human RNase H2 complex. Nucleic acids research. 2009. PMID: 19015152
- Perrino FW, Harvey S, Shaban NM. RNaseH2 mutants that cause Aicardi-Goutieres syndrome are active nucleases. Journal of molecular medicine (Berlin, Germany). 2009. PMID: 19034401
- Rice G, Patrick T, Parmar R. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. American journal of human genetics. 2007. PMID: 17846997
- Adam MP, Bick S, Mirzaa GM. Aicardi-Goutières Syndrome. 1993. PMID: 20301648